Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.
作者信息
Briani Chiara, Visentin Andrea, Salvalaggio Alessandro, Imbergamo Silvia, Piazza Francesco, Cacciavillani Mario, Campagnolo Marta, Frezzato Federica, Semenzato Gianpietro, Trentin Livio
机构信息
Neurology Unit, Department of Neuroscience, University of Padova, Italy.
Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Italy.
出版信息
Haematologica. 2017 Apr;102(4):e140-e143. doi: 10.3324/haematol.2016.153064. Epub 2016 Dec 7.
Abstract
摘要
相似文献
1
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.慢性淋巴细胞白血病中的周围神经病变：816例患者的单中心经验
Haematologica. 2017 Apr;102(4):e140-e143. doi: 10.3324/haematol.2016.153064. Epub 2016 Dec 7.
2
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of gene refines prognosis in treatment-naïve chronic lymphocytic leukemia.B细胞受体诱导的ERK1/2磷酸化与基因 突变的整合改善了初治慢性淋巴细胞白血病的预后。
Haematologica. 2017 Apr;102(4):e144-e147. doi: 10.3324/haematol.2016.154450. Epub 2016 Dec 7.
3
TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.TOSO 在中国人慢性淋巴细胞白血病患者中过表达，并与疾病进展相关。
Leuk Lymphoma. 2011 Jan;52(1):72-8. doi: 10.3109/10428194.2010.531411. Epub 2010 Dec 6.
4
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.ZAP-70表达作为慢性淋巴细胞白血病免疫球蛋白可变区突变的替代指标。
N Engl J Med. 2003 May 1;348(18):1764-75. doi: 10.1056/NEJMoa023143.
5
The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.BH3 仅蛋白 Puma 在 p53 介导的慢性淋巴细胞白血病细胞凋亡中发挥重要作用。
Leuk Lymphoma. 2013 Dec;54(12):2712-9. doi: 10.3109/10428194.2013.787613. Epub 2013 Apr 30.
6
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.慢性淋巴细胞白血病疾病严重程度和生存的临床及分子预测指标
Am J Hematol. 2007 Dec;82(12):1063-70. doi: 10.1002/ajh.20987.
7
Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.多药耐药 1 基因的多态性和单倍型与中国人群慢性淋巴细胞白血病的易感性和预后参数无关。
Leuk Lymphoma. 2011 Jun;52(6):1003-9. doi: 10.3109/10428194.2011.557454. Epub 2011 Apr 4.
8
Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.长链非编码 RNA-p21 与慢性淋巴细胞白血病的不良预后相关。
Clin Transl Oncol. 2021 Jan;23(1):92-99. doi: 10.1007/s12094-020-02398-4. Epub 2020 May 28.
9
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.MDM2基因单核苷酸多态性309与B细胞慢性淋巴细胞白血病的不良预后相关。
J Clin Oncol. 2008 May 10;26(14):2252-7. doi: 10.1200/JCO.2007.11.5212.
10
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.使用优化的流式细胞术方法对B细胞慢性淋巴细胞白血病患者ZAP-70表达的多中心研究。
Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622. Epub 2008 Jan 26.
引用本文的文献
1
Accessory Nerve Palsy as the Initial Manifestation of Chronic Lymphocytic Leukemia: A Case Report.副神经麻痹作为慢性淋巴细胞白血病的首发表现：一例报告
Am J Case Rep. 2025 Jun 1;26:e948534. doi: 10.12659/AJCR.948534.
2
Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral Neuropathy.阿卡拉布替尼和奥滨尤妥珠单抗治疗合并周围神经病变的慢性淋巴细胞白血病
Cureus. 2024 Nov 28;16(11):e74703. doi: 10.7759/cureus.74703. eCollection 2024 Nov.
3
Neurological Complications of Conventional and Novel Anticancer Treatments.传统和新型抗癌治疗的神经并发症
Cancers (Basel). 2022 Dec 10;14(24):6088. doi: 10.3390/cancers14246088.
4
Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.英国接种新型冠状病毒疫苗后发生的吉兰-巴雷综合征：一项前瞻性监测研究。
BMJ Neurol Open. 2022 Jul 12;4(2):e000309. doi: 10.1136/bmjno-2022-000309. eCollection 2022.
5
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.从具有神经学意义的单克隆丙种球蛋白病的生物学机制到治疗方法
Cancers (Basel). 2022 Mar 18;14(6):1562. doi: 10.3390/cancers14061562.
6
Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies.血液系统疾病相关神经病变中神经损伤的机制：来自神经活检的经验教训
Brain Sci. 2021 Jan 20;11(2):132. doi: 10.3390/brainsci11020132.
7
Response of multifocal acquired demyelinating sensorimotor neuropathy associated with atypical chronic lymphocytic leukemia to rituximab therapy.多灶性获得性脱髓鞘性感觉运动性神经病合并非典型慢性淋巴细胞白血病对利妥昔单抗治疗的反应
Blood Res. 2020 Jun 30;55(2):117-120. doi: 10.5045/br.2020.2020047.
本文引用的文献
1
Peripheral neuropathies.周围神经病变
Handb Clin Neurol. 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X.
2
Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.慢性淋巴细胞白血病累及中枢神经系统的患病率及特征
Haematologica. 2016 Apr;101(4):458-65. doi: 10.3324/haematol.2015.136556. Epub 2016 Jan 27.
3
The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.罕见亚型在周围神经病变诊断与治疗中的重要性：综述
JAMA Neurol. 2015 Dec;72(12):1510-8. doi: 10.1001/jamaneurol.2015.2347.
4
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.慢性淋巴细胞白血病患者感染相关的临床特征。免疫球蛋白替代疗法的保护作用。
Haematologica. 2015 Dec;100(12):e515-8. doi: 10.3324/haematol.2015.126763. Epub 2015 Aug 20.
5
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.综合慢性淋巴细胞白血病评分系统，一种预测慢性淋巴细胞白血病患者治疗时间和总生存期的新的简易指标。
Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):612-20.e1-5. doi: 10.1016/j.clml.2015.06.001. Epub 2015 Jun 20.
6
Perturbation of the normal immune system in patients with CLL.慢性淋巴细胞白血病患者正常免疫系统的紊乱。
Blood. 2015 Jul 30;126(5):573-81. doi: 10.1182/blood-2015-03-567388. Epub 2015 Jun 17.
7
Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment.伴有抗硫脂抗体和抗髓鞘相关糖蛋白抗体的多发性神经病：临床、神经生理学、病理学特征及治疗反应
J Neuroimmunol. 2015 Apr 15;281:1-4. doi: 10.1016/j.jneuroim.2015.02.009. Epub 2015 Mar 3.
8
Paraproteinemic neuropathies.副蛋白血症性神经病
Muscle Nerve. 2015 Jan;51(1):1-13. doi: 10.1002/mus.24471. Epub 2014 Nov 22.
9
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.伊布替尼与奥法妥木单抗治疗既往治疗的慢性淋巴细胞白血病。
N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31.
10
Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.来那度胺治疗化疗诱导的多发性神经病和复发/难治性多发性骨髓瘤患者：一项单中心前瞻性研究的结果。
J Peripher Nerv Syst. 2013 Mar;18(1):19-24. doi: 10.1111/jns5.12002.
Zotero 插件